KT Tape for Pediatric Clavicle Fractures

October 26, 2023 updated by: Shawn Gilbert, University of Alabama at Birmingham

KT Tape vs Arm Sling for Pediatric Clavicle Fractures

Clavicle fractures in children are mostly managed non-operatively since they have an overall high union rate (95%) and a "good" functional outcome following nonoperative treatment. However, the downside of such a conservative approach is that patients have to live with pain and disability until the fracture heals. To minimize this, fractures are usually immobilized with a sling.

There have been no studies looking at clavicle fractures treated with kinesiology (elastic) tape. No adverse effects (skin irritation, redness, etc.) are observed with the application of this tape. Elastic tape has previously been examined regarding muscular advantages rather than for healing fractures. Since this tape should immobilize fractures better than a sling, patients should experience less pain and disability associated with their fracture.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Alice Pennington, RN
  • Phone Number: 2056389540
  • Email: alicep@uab.edu

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • Recruiting
        • Children's Hospital of Alabama
        • Contact:
        • Principal Investigator:
          • Shawn R Gilbert, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 15 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Clavicle Fracture
  • Injury date within 1 week of presentation

Exclusion Criteria:

  • Underlying neuromuscular disorder (eg osteogenesis imperfecta)
  • Inability or unwillingness to report pain score until healing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Arm Sling Group
An arm sling will be applied to stabilize the clavicle fracture, thereby decreasing motion and pain.
Experimental: KT Tape Group
An arm sling will be applied to stabilize the clavicle fracture, thereby decreasing motion and pain.
in addition to an arm sling, KT Tape will be applied to stabilize the clavicle fracture, thereby decreasing motion and pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain Score
Time Frame: Twice daily for 3 weeks, and one additional time 6 weeks after the initial injnury
Participants will rate their pain on a scale from 1 to 10
Twice daily for 3 weeks, and one additional time 6 weeks after the initial injnury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Answers to DASH Questionnaire
Time Frame: Once weekly for 3 weeks, followed by one additional time 6 weeks after the initial injury.
Participants will complete the DASH questionnaire to assess disability they might be experiencing due to their fracture.
Once weekly for 3 weeks, followed by one additional time 6 weeks after the initial injury.
Change in Analgesic Use
Time Frame: Once daily for 3 weeks, and one additional time 6 weeks after the initial injnury
Participants will provide the need for taking analgesics (name, dose, and frequency).
Once daily for 3 weeks, and one additional time 6 weeks after the initial injnury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shawn R Gilbert, MD, University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

October 1, 2024

Study Registration Dates

First Submitted

October 11, 2019

First Submitted That Met QC Criteria

November 11, 2019

First Posted (Actual)

November 13, 2019

Study Record Updates

Last Update Posted (Actual)

October 30, 2023

Last Update Submitted That Met QC Criteria

October 26, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB-300004149

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clavicle Fracture

Clinical Trials on Arm Sling

3
Subscribe